StocksBio-Techne CorpTECH

TECH

Bio-Techne Corp

378.37 -11.73 (-3.01%)
Delayed Prices By NASDAQ, in USD Market Open
Trade
S
378.37
B
380.40

Overview

Prev Close390.11
Day's Range374.77 - 383.40
52 Week Range314.72 - 542.83
Average Volume (3m)194.26K
1-Year Return7.46%
Beta0.7991
Market Cap15.33B
P/E Ratio90.12
Revenue984.55M
EPS4.329
Dividend (Yield)1.28 (0.34%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Charles R. Kummeth, MBA
Employees 2,600

FINANCIAL SUMMARY

For the fiscal year ended 30/6/2021: Bio-Techne Corp's revenues increased by 26.04% and amounted to 931.03M. Net income decreased by 39.07% to 139.59M. Net assets increased by 13.76% to 1.57B and EPS decreased from 5.81 to 3.47.
TECH's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.66%
Net Profit Margin
18.53%
Operating Margin
26.89%
Return On Investment
8.10%
12/20
03/21
06/21
09/21
Total Revenue
224.25M
243.55M
259.03M
257.72M
Gross Profit
150.9M
168.27M
194.43M
189.39M
Operating Income
50.67M
68.77M
68.58M
N/A
Net Income
46.11M
45.38M
14.64M
68.98M